Jul 3, 26 · No. 083 · v1.83.0

New criteria for asthma comorbidity (c6) and untreated eosinophilic exacerbations (c7) plus refined double-therapy risk (c4) target patients needing earlier intervention.

Review supported records for potential documentation and billing gaps. Professionals validate findings; coverage and payment depend on the workflow and payer.